Hype or hope? The developing evidence base for psychedelic treatment of addiction disorders.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 40114513.
- Also identified by DOI 10.1192/bjp.2025.19.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
There has been substantial recent renewed interest and investment to assess the therapeutic potential of psychedelic compounds in addiction disorders. This editorial discusses the available evidence from randomised trials and future research directions in the field, together with potential implications for patients, professionals and the wider addiction treatment system.
Medical subject headings
- Substance-Related Disorders
- Hallucinogens